Cargando…
Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors
PURPOSE: Immune checkpoint inhibitors (ICIs) have been approved for various types of cancer; however, they cause a broad spectrum of immune-related adverse events (irAEs). The association between the development of irAEs and the clinical benefit remains uncertain. We aimed to evaluate the associatio...
Autores principales: | Shimozaki, Keitaro, Sukawa, Yasutaka, Beppu, Noriko, Kurihara, Isao, Suzuki, Shigeaki, Mizuno, Ryuichi, Funakoshi, Takeru, Ikemura, Shinnosuke, Tsugaru, Kai, Togasaki, Kazuhiro, Kawasaki, Kenta, Hirata, Kenro, Hayashi, Hideyuki, Hamamoto, Yasuo, Takaishi, Hiromasa, Kanai, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305832/ https://www.ncbi.nlm.nih.gov/pubmed/32606951 http://dx.doi.org/10.2147/CMAR.S247554 |
Ejemplares similares
-
Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors
por: Shimozaki, Keitaro, et al.
Publicado: (2021) -
The Entire Intestinal Tract Surveillance Using Capsule Endoscopy after Immune Checkpoint Inhibitor Administration: A Prospective Observational Study
por: Shimozaki, Keitaro, et al.
Publicado: (2021) -
Clinical efficacy of immune checkpoint inhibitors in the treatment of unresectable advanced or recurrent gastric cancer: an evidence-based review of therapies
por: Togasaki, Kazuhiro, et al.
Publicado: (2018) -
Inter-evaluator heterogeneity of clinical diagnosis for locally advanced esophageal squamous cell carcinoma
por: Hamamoto, Yasuo, et al.
Publicado: (2017) -
Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report
por: KAWASAKI, KENTA, et al.
Publicado: (2016)